Harrow is a fast-growing ophthalmic pharma company focused on delivering eye care drugs. Click here to read more about HROW's ...

At Lord’s Cricket Ground in the quiet, well-heeled streets of northwest London, different architectural eras collide together in a mishmash of mismatching styles representing the old and the new. A ...

Harrow’s Q3 revenue grew 44% YoY to $49.3 million, supported by increased prescriptions for Vevye and Iheezo. High SG&A costs of $33.6 million in Q3 sustained Harrow’s net loss despite gross margin ...

Harrow Health, an eye care pharmaceutical company, announced Wednesday morning that Novartis agreed to sell five drugs approved by the Food and Drug Administration for up to $175 million. Harrow will ...

Constance Grady is a senior correspondent on the Culture team for Vox, where since 2016 she has covered books, publishing, gender, celebrity analysis, and theater. I couldn’t tell that there was ...